Outcomes according to CSF3R mutation and cooccurring CEBPA or t(8;21). Outcomes for CSF3R mutant patients according to cooccurring t(8;21) or CEBPA mutation, with overall outcomes of all CSF3R⁺ patients, including either of the 2 mutations, shown as reference for (A) EFS; (B) RR; (C) OS. P values indicate differences between the t(8;21) vs CEBPA⁺ subgroups.